Executing Modern Clinical Trials Across Europe
Europe continues to play an important role in global clinical research, but its position is changing. As trial activity expands across APAC, China, Australia, and North America, sponsors are reassessing where Europe fits within modern development strategies.
This executive summary, based on a BIO Europe Spring roundtable, examines the challenges and opportunities shaping clinical trial execution across Europe.
Key insights include:
- Why Europe has lost share in global clinical trial activity
- Where the region continues to offer scientific depth and expertise
- How sponsors are weighing recruitment, regulatory timelines, and commercial priorities
- Why integrated CRO–sponsor partnerships are becoming increasingly important
- What EU initiatives may mean for Europe’s long-term competitiveness
Don’t want to receive these emails? No problem, simply click on the Unsubscribe link below.
By accessing this content, you are permitting Pharma Ignite or a third party to contact you regarding the content (by phone or email).
© 2026 Marketing Masters Hub. All rights reserved.